UNSPSC 51452307: Pyrantel pamoate

This classification denotes an antihelminthic agent with the molecular formula C23H16O6.C11H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81BK194Z5M, chemically known as (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1), but more generally known as pyrantel pamoate, which bears US NIH Compound Identifier 402. European Medicines Agency schedules pyrantel pamoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10162MIG.

UNSPSC 51452307 Pyrantel pamoate is a Commodity code that nominally identifies a specific antihelmintic pharmaceutical product, yet recent state and local opportunities show little activity directly aligned with this narrow classification. The code's title does not match the actual procurement activity appearing in the most-recent opportunities block—which spans emergency medical supplies, direct-to-manufacturer pharmacy programs, and multi-source generic pharmaceuticals through cooperative purchasing vehicles. When state and local governments do source pharmaceuticals, they typically do so through broader purchasing programs, group purchasing organizations, or cooperative agreements rather than single-product RFPs. The actual buying pattern under codes in this pharmaceutical family reflects state health departments, county health systems, and cooperative purchasing alliances procuring drug categories by therapeutic class, NDC code, or manufacturer relationship rather than by individual drug name.

Activity is geographically scattered across Florida, Texas, and Minnesota, with no concentration evident in recent postings. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with Seminole County, Florida soliciting naloxone and drug deactivation systems via IFB on June 30, 2026 (due July 26, 2023), and the Texas Health and Human Services Commission posting an RFI on April 3, 2026 regarding direct-to-manufacturer prescription programs. The City of Tampa's March 2026 medical and first aid supplies bid for the Fire Department Rescue Division, while tagged to pharmaceutical taxonomy, actually sought emergency response consumables. The code shows minimal recent opportunity volume and poor alignment between its nominal scope and actual state and local buying patterns—vendors should evaluate whether this Commodity code accurately represents their target market or whether broader pharmaceutical family codes better capture relevant solicitation activity.